These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5334 related articles for article (PubMed ID: 3942818)

  • 21. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies.
    Wagener C; Yang YH; Crawford FG; Shively JE
    J Immunol; 1983 May; 130(5):2308-15. PubMed ID: 6187849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody.
    Dippold WG; Knuth A; Meyer zum Büschenfelde KH
    Cancer Res; 1984 Feb; 44(2):806-10. PubMed ID: 6362854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody response to immunization with purified GD3 ganglioside and GD3 derivatives (lactones, amide and gangliosidol) in the mouse.
    Ritter G; Boosfeld E; Calves MJ; Oettgen HF; Old LJ; Livingston PO
    Immunobiology; 1990 Dec; 182(1):32-43. PubMed ID: 2098322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse monoclonal antibody to a melanoma-carcinoma-associated antigen synthesized by a human melanoma cell line propagated in serum-free medium.
    Chee DO; Yonemoto RH; Leong SP; Richards GF; Smith VR; Klotz JL; Goto RM; Gascon RL; Drushella MM
    Cancer Res; 1982 Aug; 42(8):3142-7. PubMed ID: 7046918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
    Togawa A; Inoue N; Mannoji M; Namba M
    Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A human monoclonal antibody encoded by the V4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1.
    Thomas MD; Clough K; Melamed MD; Stevenson FK; Chapman CJ; Spellerberg MB; Potter KN; Newton-Bishop JA; Gregson N; Dawson K
    Hum Antibodies; 1999; 9(2):95-106. PubMed ID: 10405830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production and potential use of monoclonal antibodies against polio viruses.
    Osterhaus AD; van Wezel AL; van Steenis G; Hazendonk AG; Drost G
    Dev Biol Stand; 1981; 50():221-8. PubMed ID: 6281107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
    Chapman PB; Wu D; Ragupathi G; Lu S; Williams L; Hwu WJ; Johnson D; Livingston PO
    Clin Cancer Res; 2004 Jul; 10(14):4717-23. PubMed ID: 15269144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific serological response by active immunization with GD3-bearing liposomes.
    Massó O; Aliño SF; Lejarreta M; Blasco F; Piulats J
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1114-20. PubMed ID: 8819493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of monoclonal antibodies to human melanoma-associated antigens.
    Imai K; Ng AK; Ferrone S
    J Natl Cancer Inst; 1981 Mar; 66(3):489-96. PubMed ID: 6162991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma antibodies: specificity and interaction with melanoma and cytotoxic T-cells.
    Dippold WG; Knuth A; Meyer zum Büschenfelde KH
    Behring Inst Mitt; 1984 May; (74):14-8. PubMed ID: 6332614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Monoclonal antibodies against human differentiated thymocyte antigens].
    Baryshnikov AIu
    Biull Eksp Biol Med; 1984 Sep; 98(9):324-6. PubMed ID: 6333255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies.
    Brown JP; Nishiyama K; Hellström I; Hellström KE
    J Immunol; 1981 Aug; 127(2):539-46. PubMed ID: 6166674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and characterization of monoclonal antibodies against human epidermal growth factor receptor in Balb/c mice.
    Baradaran B; Hosseini AZ; Majidi J; Farajnia S; Barar J; Saraf ZH; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(1-2):11-6. PubMed ID: 19478394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Production of monoclonal antibody with anti-B specificity, to be used as reagent for blood classification].
    León G; Cruz C; Rojas L
    Invest Clin; 2004 Jun; 45(2):145-57. PubMed ID: 15211982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant.
    McCaffery M; Yao TJ; Williams L; Livingston PO; Houghton AN; Chapman PB
    Clin Cancer Res; 1996 Apr; 2(4):679-86. PubMed ID: 9816218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.
    Haynes BF; Hemler M; Cotner T; Mann DL; Eisenbarth GS; Strominger JL; Fauci AS
    J Immunol; 1981 Jul; 127(1):347-51. PubMed ID: 6787129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 267.